Indivior Announces a New $100 Million Share Repurchase Program; New Program will be Executed Over an Accelerated Time Frame

Core Viewpoint - Indivior PLC has announced a new share repurchase program with a maximum consideration of $100 million to reduce its issued share capital, expected to be completed within six months [2][4]. Group 1: Share Repurchase Program - The new share repurchase program will commence after the completion of the current program, which is expected to finish by the end of July 2024 [10]. - Indivior has entered into a non-discretionary agreement with Morgan Stanley to conduct on-market purchases of ordinary shares as riskless principal [3][11]. - The maximum number of ordinary shares that may be repurchased under the new program is 13,649,017, as authorized by the company's shareholders [12]. Group 2: Company Overview - Indivior is a leading addiction treatment company focused on developing medicines for substance use disorders and related conditions [14]. - The company employs over 1,000 individuals globally and its products are available in 37 countries [7].